A prescription cream containing ivermectin 1%, originally developed to treat rosacea by reducing inflammation and targeting demodex mites.
Guru Score
The Guru Score: every expert's verdict on a product, in one simple number.
Under the score you'll see how many experts weighed in, or "Early verdict" while only a few have. Paid takes count for half in the score.
Guru Certified means at least 6 experts, a score of 85% or more, and almost no Nays.
How we score →Yay
3 experts · Moderate agreementWhat the gurus are saying
Ivermectin's anti-inflammatory power and ability to kill demodex mites make it remarkably effective for rosacea and perioral dermatitis, especially when other ingredients haven't worked. The major caveat is cost: at $600-plus per tube, most insurance won't cover it, though generic and compounded versions are now available at lower prices. That price barrier can be a real hurdle, so exploring those alternatives may be worth asking your dermatologist about.
What they liked
What they flagged
Every take we've logged from this product's reviews across YouTube. Click any row to watch the moment they said it.
Independent of what the gurus think, this is what the published research supports about the main active ingredients here.
A prescription cream containing ivermectin 1%, originally developed to treat rosacea by reducing inflammation and targeting demodex mites.
Mostly yes. 2 of the 3 gurus who reviewed it give it their stamp of approval, for a Guru Score of 79%.
Soolantra Ivermectin Cream 1% holds a Guru Score of 79%. That is our read on how warmly the experts talk about it, based on the verdicts of 3 expert reviewers we have collected.
Soolantra Ivermectin Cream 1% is generally suited to sensitive skin and acne-prone skin.
Lower-priced moisturizers the gurus still rate highly, versus this mid-range pick.
See how they stack up →Other products the same gurus have weighed in on, plus more from this brand and category.
Compare side by side →Stories where our editors dug into this product or its brand.
Spotted something on this page that doesn't look right? Let us know.
A weekly read of the takes worth catching up on: the raves, the splits, the ones the gurus won't shut up about. Free, no spam, unsubscribe whenever.
Subscribe to the digest